We are live on
!
Find out more
NYLT
New York Life Trust Portfolio holdings
AUM
$2.05M
1-Year Est. Return
23.85%
This Fund
S&P 500
This Quarter
Est. Return
+12.57%
1 Year Est. Return
+23.85%
3 Year Est. Return
+57.22%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$22M
AUM Growth
+$2.05M
(+10%)
Cap. Flow
-$229K
Cap. Flow
% of AUM
-1.04%
Top 10 Holdings %
Top 10 Hldgs %
20.43%
Holding
232
New
40
Increased
52
Reduced
95
Closed
43
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$179K |
| 2 |
Merck
MRK
|
+$163K |
| 3 |
Halliburton
HAL
|
+$138K |
| 4 |
VIAB
Viacom Inc. Class B
VIAB
|
+$131K |
| 5 |
Altria Group
MO
|
+$124K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$198K |
| 2 |
Gilead Sciences
GILD
|
+$157K |
| 3 |
CELG
Celgene Corp
CELG
|
+$150K |
| 4 |
Cencora
COR
|
+$111K |
| 5 |
FITB
Fifth Third Bancorp
FITB
|
+$104K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.8% |
| 2 | Financials | 14.52% |
| 3 | Healthcare | 14.1% |
| 4 | Industrials | 11.71% |
| 5 | Consumer Staples | 9.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Broadridge
BR
$18.6B
| $42K | 0.19% |
1,061
+133
| +14% | +$4.8K |
|
152
Mondelez International
MDLZ
$79.9B
| $42K | 0.19% |
1,198
-1,120
| -48% | -$37.2K |
|
153
CVS Health
CVS
$126B
| $41K | 0.19% |
569
+309
| +119% | +$19.9K |
|
|
GAP
154
The Gap Inc
GAP
$7.4B
| $41K | 0.19% |
1,051
-1,429
| -58% | -$55.9K |
|
155
Moody's
MCO
$83.8B
| $40K | 0.18% |
511
+258
| +102% | +$18.9K |
|
156
Tapestry
TPR
$32.2B
| $40K | 0.18% |
711
+671
| +1,678% | +$36.3K |
|
|
CELG
157
DELISTED
Celgene Corp
CELG
| $40K | 0.18% |
468
-1,892
| -80% | -$150K |
|
158
Agilent Technologies
A
$39.9B
| $39K | 0.18% |
960
-663
| -41% | -$25.2K |
|
159
Aptiv
APTV
$9.76B
| $38K | 0.17% |
+640
| New | +$37K |
|
160
Kimberly-Clark
KMB
$37.4B
| $34K | 0.15% |
339
-509
| -60% | -$50.8K |
|
161
Humana
HUM
$43.7B
| $33K | 0.15% |
+319
| New | +$31.3K |
|
|
BRCM
162
DELISTED
BROADCOM CORP CL-A
BRCM
| $32K | 0.15% |
+1,084
| New | +$29.5K |
|
|
LLL
163
DELISTED
L3 Technologies, Inc.
LLL
| $30K | 0.14% |
280
+236
| +536% | +$23.6K |
|
164
Edison International
EIX
$26.3B
| $29K | 0.13% |
+626
| New | +$29.6K |
|
165
RTX Corp
RTX
$300B
| $28K | 0.13% |
385
-139
| -27% | -$9.47K |
|
166
PPG Industries
PPG
$26.5B
| $27K | 0.12% |
284
-350
| -55% | -$31.5K |
|
167
Duke Energy
DUK
$96.2B
| $26K | 0.12% |
373
+50
| +15% | +$3.5K |
|
168
Nabors Industries
NBR
$1.16B
| $24K | 0.11% |
28
+21
| +300% | +$17.8K |
|
|
KRFT
169
DELISTED
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
| $22K | 0.1% |
401
-362
| -47% | -$19.3K |
|
|
CVC
170
DELISTED
CABLEVISION SYS CP NY GRP CL-A
CVC
| $20K | 0.09% |
1,097
-3,327
| -75% | -$53.8K |
|
|
171
Bristol-Myers Squibb
BMY
$130B
| $18K | 0.08% |
345
-3,894
| -92% | -$198K |
|
172
AutoZone
AZO
$50.1B
| $17K | 0.08% |
+35
| New | +$15.7K |
|
173
Biogen
BIIB
$30.5B
| $17K | 0.08% |
62
-236
| -79% | -$61K |
|
174
Emerson Electric
EMR
$90.6B
| $15K | 0.07% |
209
+178
| +574% | +$11.9K |
|
|
TYC
175
DELISTED
TYCO INTL PLC COM SHS (IRL)
TYC
| $13K | 0.06% |
296
-285
| -49% | -$11.1K |
|
Similar funds
SFM
LWMG
PLP
AS
AGI
SCA
FREIGI
MMI
New York Life Trust's Q4 2013 Portfolio in Review
As of Q4 2013, New York Life Trust held 232 positions worth $22M, up 10% from $19.9M the previous quarter. Its ten largest holdings account for 20% of the portfolio.
New York Life Trust's Q4 2013 filing shows 40 new, 52 increased, 95 reduced and 43 closed positions. Its largest new stake was Halliburton: 2,668 shares worth $135K. The largest sale was Bristol-Myers Squibb, an estimated $198K.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Financials and Healthcare.
- New York Life Trust's largest Q4 2013 buy was Halliburton: 2,668 shares worth $135K.
- New York Life Trust added most to UnitedHealth in Q4 2013, an estimated $179K increase.
- New York Life Trust's biggest Q4 2013 reduction was Bristol-Myers Squibb, cutting an estimated $198K.
- New York Life Trust fully exited Cencora in Q4 2013, selling an estimated $111K.
- New York Life Trust's ten largest holdings make up 20% of its $22M portfolio in Q4 2013.
- New York Life Trust opened 40 new positions and closed 43 in Q4 2013.
- New York Life Trust's portfolio value rose 10% quarter-over-quarter to $22M.
Based on New York Life Trust's 13F filing for Q4 2013, filed 14 Feb 2014.